Fax: (215) 214-1629
Article first published online: 20 JAN 2009
Copyright © 2009 American Cancer Society
Volume 115, Issue 5, pages 946–951, 1 March 2009
How to Cite
Freedman, G. M., Anderson, P. R., Li, T. and Nicolaou, N. (2009), Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation . Cancer, 115: 946–951. doi: 10.1002/cncr.24094
Presented in abstract form at the 89th Annual Meeting of the American Radium Society, Amsterdam, the Netherlands, May 5-9, 2007.
We thank Cindy Rosser for her collection and management of the data for the study population, and Lillian Henry for her assistance in the preparation of the article.
- Issue published online: 18 FEB 2009
- Article first published online: 20 JAN 2009
- Manuscript Accepted: 10 SEP 2008
- Manuscript Revised: 22 AUG 2008
- Manuscript Received: 11 JUL 2008
- breast cancer;
- hormone receptor-negative;
- basal-like breast cancer
The results of radiation on the local control of triple receptor-negative breast cancer (negative estrogen [ER], progesterone [PR], and HER-2/neu receptors) was studied.
Conservative surgery and radiation were used in 753 patients with T1-T2 breast cancer. Three groups were defined by receptor status: Group 1: ER or PR (+); Group 2: ER and PR (−) but HER-2 (+); and Group 3: triple-negative (TN). Factors analyzed were age, menopausal status, race, stage, tumor size, lymph node status, presentation, grade, extensive in situ disease, margins, and systemic therapy. The primary endpoint was 5-year locoregional recurrence (LRR) isolated or total with distant metastases.
ER- and PR-negative patients were statistically significantly more likely to be black, have T2 disease, have tumors detectable on both mammography and physical examination, have grade 3 tumors, and receive chemotherapy. There were no significant differences noted with regard to ER− and PR− patients by HER-2 status. There was a significant difference noted in rates of first distant metastases (3%, 12%, and 7% for Groups 1, 2, and 3, respectively; P = .009). However, the isolated 5-year LRR was not significantly different (2.3%, 4.6%, and 3.2%, respectively; P = .36) between the 3 groups.
Patients with TN breast cancer do not appear to be at a significantly increased risk for isolated LRR at 5 years and therefore remain appropriate candidates for breast conservation. Cancer 2009. © 2009 American Cancer Society.